These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 26690040)
21. Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis. Lang K; Bozkaya D; Patel AA; Macomson B; Nelson W; Owens G; Mody S; Schein J; Menzin J BMC Health Serv Res; 2014 Jul; 14():329. PubMed ID: 25069459 [TBL] [Abstract][Full Text] [Related]
22. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231 [TBL] [Abstract][Full Text] [Related]
23. Warfarin therapy for atrial fibrillation in general practice--is bleeding risk underestimated? Bratland B; Hornnes MB Tidsskr Nor Laegeforen; 2014 Jan; 134(2):175-9. PubMed ID: 24477151 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of stroke and the need for thromboprophylaxis in young patients with atrial fibrillation: a cohort study. Lin AH; Oakley LS; Phan HL; Shutt BJ; Birgersdotter-Green U; Francisco GM J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):189-93. PubMed ID: 24625564 [TBL] [Abstract][Full Text] [Related]
25. [Atrial fibrillation and stroke]. Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293 [TBL] [Abstract][Full Text] [Related]
26. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389 [TBL] [Abstract][Full Text] [Related]
27. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. Lip GY; Frison L; Halperin JL; Lane DA J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555 [TBL] [Abstract][Full Text] [Related]
28. CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study. Toyoda K; Yasaka M; Uchiyama S; Iwade K; Koretsune Y; Nagata K; Sakamoto T; Nagao T; Yamamoto M; Gotoh J; Takahashi JC; Minematsu K; Hypertens Res; 2014 May; 37(5):463-6. PubMed ID: 24196199 [TBL] [Abstract][Full Text] [Related]
29. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S; Bennett D; Smith DJ Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933 [TBL] [Abstract][Full Text] [Related]
31. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk. Potpara TS; Lip GY Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958 [TBL] [Abstract][Full Text] [Related]
32. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422 [TBL] [Abstract][Full Text] [Related]
33. Bleeding as an outcome among patients with nonvalvular atrial fibrillation in a large managed care population. Deitelzweig SB; Pinsky B; Buysman E; Lacey M; Makenbaeva D; Wiederkehr D; Graham J Clin Ther; 2013 Oct; 35(10):1536-45.e1. PubMed ID: 24075151 [TBL] [Abstract][Full Text] [Related]
34. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
35. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
37. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928 [TBL] [Abstract][Full Text] [Related]
38. The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation. Frain BE; Castelino R; Bereznicki L Clin Appl Thromb Hemost; 2017 Sep; 23(6):671-676. PubMed ID: 26994296 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients. Berti D; Moors E; Moons P; Heidbuchel H Heart; 2015 Jun; 101(11):884-93. PubMed ID: 25872523 [TBL] [Abstract][Full Text] [Related]
40. The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial Fibrillation. Frain B; Castelino R; Bereznicki LR Clin Appl Thromb Hemost; 2018 Apr; 24(3):519-524. PubMed ID: 28068791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]